Price $88.43 |
Market Cap
1.07B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
58.8
|
P/B
3.68
|
P/S
1.89
|
Dividend %
-
|
|
P/CF
121.2
|
P/FCF
101.1
|
Op. Cash Flow
15.7K
|
FCF
0.7
|
|
Op. Margin
4.70%
|
Net Margin
3.20%
|
ROE
6.90%
|
ROI
6.80%
|
|
ROA
4.60%
|
EPS Growth
13.00%
|
Current Ratio
3.0
|
Debt/Equity
6.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $38.41 | - | - | 1.04B | Strong Buy |
| TearLab Corp (TEAR) | $0.07 | - | - | 900K | Strong Buy |
| CVS Health Corp (CVS) | $60.28 | - | 3.60% | 71.93B | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.57 | - | - | 28.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.80 | - | - | 43.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
